Free Trial
→ Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom (From Brownstone Research) (Ad) Free RENB Stock Alerts

Renovaro (RENB) News Today

Renovaro logo
$0.28 +0.01 (+3.70%)
Closing price 07/14/2025 04:00 PM Eastern
Extended Trading
$0.28 0.00 (-0.71%)
As of 07/14/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

RENB Latest News

Renovaro Biosciences Receives Nasdaq Compliance Notice
July 14 at 10:23 AM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/renovaro-biosciences-receives-nasdaq-compliance-notice?utm_source=marketbeat.com&utm_medium=referral
Renovaro Strengthens Balance Sheet Through Debt ... - Morningstar
July 11, 2025  |  morningstar.comM
Renovaro Biosciences Restructures Debt with Exchange Agreement
July 9, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/renovaro-biosciences-restructures-debt-with-exchange-agreement?utm_source=marketbeat.com&utm_medium=referral
Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs - Nasdaq
July 2, 2025  |  nasdaq.comhttps://www.nasdaq.com/press-release/renovaro-launches-ai-based-neurotoxin-countermeasure-initiative-addressing-emerging
Renovaro Biosciences: Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs - FinanzNachrichten.de
July 2, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-06/65789917-renovaro-biosciences-renovaro-launches-ai-based-neurotoxin-countermeasure-initiative-addressing-emerging-national-security-needs-200.htm
Renovaro (NASDAQ:RENB) Shares Down 1.3% - Time to Sell?
July 1, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/renovaro-nasdaqrenb-shares-down-13-time-to-sell-2025-07-01/
Renovaro subsidiary secures patent for drug discovery AI
June 5, 2025  |  uk.investing.comhttps://uk.investing.com/news/company-news/renovaro-subsidiary-secures-patent-for-drug-discovery-ai-93CH-4117129
RENB-aandeel raakt 52-weeks dieptepunt van $ 0,27 door marktuitdagingen
June 5, 2025  |  nl.investing.comhttps://nl.investing.com/news/company-news/renbaandeel-raakt-52weeks-dieptepunt-van--027-door-marktuitdagingen-93CH-510928
RENB stock touches 52-week low at $0.27 amid market challenges
June 5, 2025  |  investing.comhttps://www.investing.com/news/company-news/renb-stock-touches-52week-low-at-027-amid-market-challenges-93CH-4078901
Renovaro Obtains a U.S. Patent for its AI-Powered Platform for Medication Discovery and Diagnostics
June 5, 2025  |  msn.comhttps://www.msn.com/en-us/health/medical/renovaro-obtains-a-u-s-patent-for-its-ai-powered-platform-for-medication-discovery-and-diagnostics/ar-AA1G6nQ1
Renovaro-dochter verkrijgt patent voor AI-gestuurde medicijnontwikkeling
June 3, 2025  |  nl.investing.comhttps://nl.investing.com/news/company-news/renovarodochter-verkrijgt-patent-voor-aigestuurde-medicijnontwikkeling-93CH-510591
Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform
June 3, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/03/3092863/0/en/renovaro-secures-key-u-s-patent-to-strengthen-ai-driven-drug-discovery-and-diagnostics-platform.html
Renovaro Inc. Secures Ruling to Expedite Trial Against Predictive Oncology Over Breach of Merger Agreement
May 24, 2025  |  nasdaq.comhttps://www.nasdaq.com/articles/renovaro-inc-secures-ruling-expedite-trial-against-predictive-oncology-over-breach-merger
Renovaro Inc. Accelerates 2025 Lawsuit to Force Predictive Oncology Merger
May 22, 2025  |  insidermonkey.comhttps://www.insidermonkey.com/blog/renovaro-inc-accelerates-2025-lawsuit-to-force-predictive-oncology-merger-1539681/
UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
May 22, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/22/3087036/0/en/update-renovaro-inc-announces-expedited-trial-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology.html
Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
May 22, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/22/3086849/0/en/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology.html
Renovaro partners with Amsterdam UMC on cancer diagnostics
May 15, 2025  |  uk.investing.comhttps://uk.investing.com/news/company-news/renovaro-partners-with-amsterdam-umc-on-cancer-diagnostics-93CH-4083323
Renovaro lanceert AI-platform voor versnelling neurologische medicijnontwikkeling
May 15, 2025  |  nl.investing.comhttps://nl.investing.com/news/company-news/renovaro-lanceert-aiplatform-voor-versnelling-neurologische-medicijnontwikkeling-496022
Renovaro Inc. and Amsterdam UMC Enter Exclusive Collaboration to Develop Blood Platelet RNA Diagnostics
May 15, 2025  |  nasdaq.comhttps://www.nasdaq.com/articles/renovaro-inc-and-amsterdam-umc-enter-exclusive-collaboration-develop-blood-platelet-rna
Renovaro launches AI platform to advance neurology drug discovery
May 15, 2025  |  investing.comhttps://www.investing.com/news/company-news/renovaro-launches-ai-platform-to-advance-neurology-drug-discovery-93CH-4045194
Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform
May 14, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/14/3081222/0/en/renovaro-launches-augusta-an-ai-powered-precision-neurology-platform.html
Renovaro gaat samenwerking aan met Amsterdam UMC voor kankerdiagnostiek
May 13, 2025  |  nl.investing.comhttps://nl.investing.com/news/company-news/renovaro-gaat-samenwerking-aan-met-amsterdam-umc-voor-kankerdiagnostiek-93CH-494601
Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics
May 13, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/13/3080252/0/en/renovaro-and-amsterdam-university-medical-center-announce-exclusive-collaboration-to-advance-blood-platelet-rna-diagnostics.html
Renovaro Inc. (NASDAQ:RENB) Shares Acquired by Geode Capital Management LLC
May 2, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/renovaro-inc-nasdaqrenb-shares-acquired-by-geode-capital-management-llc-2025-04-30/
RENB-aandeel raakt 52-weeks dieptepunt van $ 0,32 door marktuitdagingen
May 1, 2025  |  nl.investing.comhttps://nl.investing.com/news/company-news/renbaandeel-raakt-52weeks-dieptepunt-van--032-door-marktuitdagingen-93CH-482431
Renovaro BioSciences expands collaboration with Nebul
April 23, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/renovaro-biosciences-expands-collaboration-with-nebul-1034609028
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs
April 22, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/04/22/3065601/0/en/renovaro-secures-high-powered-computing-from-nebul-through-a-partnership-to-accelerate-next-generation-biomarker-discovery-and-diagnostic-programs.html
Renovaro riskeert Nasdaq-notering te verliezen door te lage aandelenkoers
April 18, 2025  |  nl.investing.comhttps://nl.investing.com/news/sec-filings/renovaro-riskeert-nasdaqnotering-te-verliezen-door-te-lage-aandelenkoers-93CH-473955
Renovaro BioSciences, BioSymetrics close merger transaction
April 9, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/renovaro-biosciences-biosymetrics-close-merger-transaction-1034566934
Renovaro Inc: Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine
April 9, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-04/65072195-renovaro-inc-renovaro-and-biosymetrics-close-merger-to-accelerate-ai-driven-biomarker-discovery-and-precision-medicine-399.htm
Renovaro fuseert met BioSymetrics voor AI-gedreven medicijnontwikkeling
April 9, 2025  |  nl.investing.comhttps://nl.investing.com/news/company-news/renovaro-fuseert-met-biosymetrics-voor-aigedreven-medicijnontwikkeling-93CH-468553
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine
April 9, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/04/09/3058523/0/en/renovaro-and-biosymetrics-close-merger-to-accelerate-ai-driven-biomarker-discovery-and-precision-medicine.html
Predictive Oncology Ends Merger Talks with Renovaro
April 7, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/predictive-oncology-ends-merger-talks-with-renovaro?utm_source=marketbeat.com&utm_medium=referral
Renovaro Biosciences stuit op tegenslag bij fusie met Predictive Oncology
April 6, 2025  |  nl.investing.comhttps://nl.investing.com/news/company-news/renovaro-biosciences-stuit-op-tegenslag-bij-fusie-met-predictive-oncology-93CH-466086
Renovaro Inc: Renovaro Provides Update to Definitive Agreement with Predictive Oncology
April 4, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-04/65031964-renovaro-inc-renovaro-provides-update-to-definitive-agreement-with-predictive-oncology-399.htm
Renovaro BioSciences provides update to agreement with Predictive Oncology
April 4, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/renovaro-biosciences-provides-update-to-agreement-with-predictive-oncology-1034551870
Renovaro Shares Fall After Merger Setback
April 4, 2025  |  marketwatch.comhttps://www.marketwatch.com/story/renovaro-shares-fall-after-merger-setback-1970c821
Renovaro says Predictive Oncology terminates merger transaction
April 4, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/renovaro-says-predictive-oncology-terminates-merger-transaction-1034551913
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
April 4, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/04/04/3056001/0/en/renovaro-provides-update-to-definitive-agreement-with-predictive-oncology.html
Renovaro Biosciences Advances Financing for AI-Driven Integration and Strategic Expansion in Oncology through Acquisition of Predictive Oncology
March 5, 2025  |  nasdaq.comhttps://www.nasdaq.com/articles/renovaro-biosciences-advances-financing-ai-driven-integration-and-strategic-expansion
Renovaro (RENB) and Predictive Oncology Partner for AI-Driven Drug Discovery: What’s Next for Cancer and HIV Treatments?
March 4, 2025  |  insidermonkey.comhttps://www.insidermonkey.com/blog/renovaro-renb-and-predictive-oncology-partner-for-ai-driven-drug-discovery-whats-next-for-cancer-and-hiv-treatments-1470808/
Renovaro provides financing to Predictive Oncology as both move to finalize definitive merger agreement
March 3, 2025  |  bizjournals.comhttps://www.bizjournals.com/pittsburgh/news/2025/03/03/predictive-predicts-merger-agreement-soon.html
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
March 3, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/03/03/3035729/0/en/renovaro-completes-first-milestone-payment-to-finalize-definitive-agreement-with-predictive-oncology.html
Renovaro Biosciences Buys AI-Driven BioSymetrics
February 27, 2025  |  marketwatch.comhttps://www.marketwatch.com/story/renovaro-biosciences-buys-ai-driven-biosymetrics-9d653490
Renovaro Inc. (RENB) Merges with BioSymetrics to Advance AI-Driven Cancer Research
February 27, 2025  |  msn.comhttps://www.msn.com/en-us/technology/artificial-intelligence/renovaro-inc-renb-merges-with-biosymetrics-to-advance-ai-driven-cancer-research/ar-AA1zWwdN
Renovaro Inc: Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
February 27, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-02/64669876-renovaro-inc-renovaro-and-biosymetrics-announce-definitive-merger-agreement-to-advance-ai-driven-biomarker-discovery-and-precision-medicine-399.htm
Renovaro BioSciences announces $15M in equity committed
February 27, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/renovaro-biosciences-announces-15m-in-equity-committed-1034412340
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
February 26, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/02/26/3033213/0/en/renovaro-and-biosymetrics-announce-definitive-merger-agreement-to-advance-ai-driven-biomarker-discovery-and-precision-medicine.html
Renovaro Announces $15 million in Equity Committed
February 26, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/02/26/3033011/0/en/renovaro-announces-15-million-in-equity-committed.html
Renovaro (NASDAQ:RENB) Posts Earnings Results
February 20, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/renovaro-nasdaqrenb-posts-earnings-results-2025-02-19/
Get Renovaro News Delivered to You Automatically

Sign up to receive the latest news and ratings for RENB and its competitors with MarketBeat's FREE daily newsletter.

RENB Media Mentions By Week

RENB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RENB
News Sentiment
▼
0.07

0.99
▲
Average
Medical
News Sentiment

RENB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RENB Articles
This Week
▼
4

2
▲
RENB Articles
Average Week

Get Renovaro News Delivered to You Automatically

Sign up to receive the latest news and ratings for RENB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies
Headlines Tools

This page (NASDAQ:RENB) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...
Paradigm Press | Sponsored
[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...
Golden Portfolio | Sponsored
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...
Crypto 101 Media | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored